2018 Meeting Archive

During 2018 Beacon Angels entertained new funding proposals from companies and due diligence reports, respectively, as follows :

January 9, 2018

  • Meenta which helps scientists more fully access costly and limited laboratory resources by finding, accessing and sending biological samples to idle equipment via the Cloud; and
  • Tӧst Beverages, which develops and sells uniquely delicious non-alcoholic celebratory beverages.

February 13, 2018

  • Jobletics, an on-demand temp staffing marketplace for the food service and hospitality industry, and
  • Name Net Worth, which offers an app to convert your networking activity into sales opportunities.

Members’ due diligence reports: Magurobotics, and Töst Beverages. 

March 13, 2018

  • GoPetie, a B2B & B2C mobile platform that connects pet owners to each other, to local service providers and municipalities in a social community environment, and
  • GuruSnaps, which connects business owners with professionals (Gurus) who can help them sell their business on the best terms.

Members’ due diligence reports: Töst and Jobletics.

April 10, 2018

  • Rockstep Solutions, which offers Climb, a scalable SaaS animal laboratory informatics software product that is designed in the Azure™ Cloud to leverage smart-lab technologies and utilize more elastic resources.

Due diligence update: Tӧst,

Beacon hosted funding updates by the CEOs of Pykus Therapeutics, and Spiro Technologies.

May 8, 2018

  • Zippity Cars, which offers maintenance services directly to car owners at their place of business,
  • BioTrak Therapeutics, which offers a mobile behavioral health app for the 2.4 billion people worldwide who suffer from frequently recurring tension-type headaches & migraines, and
  • ScholarJet, where students earn college scholarships and companies reach a talented pool of college students, vet candidates for internships and employment, and enhance their employer brand.

We heard an update on Meenta, a prior Beacon presenter.

June 12, 2018

  • LASO Technologies, which is selling a very waterproof Iphone case and is developing other field-use Iphone accessories; and
  • ENTERAstim, which is developing a therapeutic system to stimulate the small bowel in the human GI tract electrically and speed the return of its motility from ileus to normal.

We also heard:

  • Due diligence reports on Zippity Cars and on ScholarJet, and
  • An update from the CEO and founder of portfolio company Ecare Vault.

Finally, we conducted a full review of the health and prospects of the companies in the Beacon Angels portfolio.

July 10, 2018

  • Waec, which provides a low-cost, efficient local delivery option for consumers and stores using autonomous ground drones that politely navigate sidewalks and crosswalks, and
  • Mobile Price Card is which offers a patent-pending technology to help consumer electronics retailers improve sales by advertising on the screens of devices already on display.

September 11, 2018

  • QMedic, which offers a smart emergency help button service partnered with health insurers to support high-risk members living at home; and
  • Datarista, a platform for data providers in the third-party Sales & Marketing data industry to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua.

Member reports:

  • Beacon’s participation in any extension of the Zippity round; and
  • Update on the pending bridge round by Siamab Therapeutics.

October 9, 2018

  • Omega Trace, which is offering a product suite for brick and mortar businesses to monitor and track visitors to their premises, and
  • Weft-Tex, which has developed and is selling a proprietary breath-through crib mattress.

Member updates and due diligence: Datarista, and Zippity Cars.

November 13, 2018

  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system to diagnose antibiotic-resistant infections in hospitals; and
  • Enviro Power, which has developed the SmartWatt™ Boiler, a 95% efficient, closed-loop micro steam turbine for heating systems in homes and businesses to generate electric power on-site both as a backup and more cheaply than grid-supplied power.

Members’ due diligence reports and company updates:

  • Datarista, a platform in the third-party Sales & Marketing data industry for data providers to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua; and
  • Concrete Sensors, which is selling a system for building professionals to monitor and control the concrete curing process.

December 11, 2018

  • Invitrometrix, which has developed and is selling devices to life science research and drug discovery companies that uniquely provide continuous, real-time, quantitative monitoring of cells in culture, and
  • Walch High School Math, which automates the development and deployment of high school curricula, giving school districts a virtual curriculum department in the cloud.

Member Due Diligence:

  • Datarista, which offers a data platform for the Sales & Marketing data industry; and
  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system for the on-site diagnosis of antibiotic-resistant infections in hospitals.
Posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations, Uncategorized | Tagged , , , | Leave a comment

Gynion & IdleSmart

At its meeting the morning of Flag Day 2022, Beacon Angels members considered funding proposals from the following companies:

  • Mr. Oleg Shikhman, CEO, Gynion—developing MenorrxTM treatment for Heavy Menstrual Bleeding (HMB), Menorrx is a safe and effective endometrial ablation therapy that is simpler, easier to use, and costs a fraction of the available alternatives;
  • Mr. Jeff Lynch, CEO, presenting remotely regarding IdleSmart—offering a proprietary IoT solution for truck fleets to reduce yearly fuel costs of $10,000 per truck while increasing vehicle uptime and availability; and
  • Mr. Doug Godfrin, CEO, who delivered an update on Veramorph, which reformulates generic drugs for oral efficacy and is co-developing a diverse portfolio of new drugs with a beachhead in the oral delivery of a drug treatment for metastatic breast cancer.

There followed a due diligence report on Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities.

Members reported on the funding rounds of:

TopProp Fantasy, which has finalized the terms of its convertible note; and

Imago Rehab, which has accepted an extension of BA Series 99’s investment.

Members delivered company updates.

Posted in Beacon Angels Events, Beacon Angels Exits, Beacon Events, Boston angel investing | Tagged , , , , | Leave a comment

Bloom for All & OrderTaker Solutions

At the Beacon Angels meeting held on Tuesday, May 12, 2022, we entertained funding proposals from the following new company presenters:

  • BloomForAll (Joanne Mercaldi & Team), offering teenagers a safe, inclusive and mindful health information platform powered by doctors, educators, organizations, and social influencers; and
  • OrderTaker Solutions (Amit Gathani), a Wholesale Distribution technology startup developing a mobile ordering app for field sales reps to engage in direct store delivery sales and increase sales revenues by at least 15-20%.

Members delivered a report on The New England Quarterly Summit of the Angel Capital Association held on May 4, 2022.

We also heard member due diligence reports on the following:

  • Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities;
  • Encapsulate, developing automated tumor-on-a-chip systems that can grow patients’ cancer cells and test the efficacy of cancer drugs; and
  • Connective Health, disrupting behavioral health care.
Posted in Uncategorized | Leave a comment

Pointz Mobility & The Family Learning Company

At the Beacon Angels meeting held on April 12, 2022, we entertained new funding proposals from the following:

  • Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities; and
  • The Family Learning Company, creating literacy software that connects adult learners and their children.

We discussed the funding rounds of Jaia Robotics, and Imago Rehab.

We discussed due diligence reports as to Shoreline BiomeTopProp Fantasy, Encapsulate and Connective Health.

Posted in Beacon Events, Boston angel investing, Boston Startups, Past Beacon Meetings | Tagged , , , | Leave a comment

Contacts411 & Connective Health

At the Beacon Angels meeting on March 8, 2022, we entertained funding proposals from the following:

  • Ryan Hess, of Contacts411, which provides contact data enhancement and updating for very small businesses; and
  • Karen Sallick, of Connective Health, providing a SAAS platform to help primary care providers deliver behavioral healthcare (diagnosis and treatment of mental health, substance abuse, and associated physical disorders).

We discussed the funding rounds of Jaia Robotics, and Imago Rehab.

We discussed due diligence as to Dyad Medical, Shoreline Biome, TopProp Fantasy, and Encapsulate.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups | Tagged , , , | Leave a comment

TopProp Fantasy & Encapsulate

At the Beacon meeting held on February 8, 2022, members entertained new company funding proposals from the following:

  • TopProp Fantasy, offering a daily fantasy sports platform that simplifies DFS down to its core: single-player fantasy; and
  • Encapsulate, which is develops an automated tumor-on-a-chip system to grow patient-derived microtumors, to screen them against a variety of chemotherapeutic drugs.

Members reported on the new company funding round of NF2 Therapeutics, together with that of Cognoptix, which raised $740K of a targeted $500-$700K convertible debt round to revamp and supplement the results of its most recent clinical trials.

Members delivered due diligence reports on the following companies:

  • Dyad Medical, which is developing AI-enabled clinical applications to assist cardiologists in the interpretation of medical images;
  • Jaia Robotics, developing “JaiaBots,” low-cost, high-speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters down to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab, providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation to hand-impaired stroke patients.

Beacon Angels members delivered company updates.

Posted in Beacon Angels Events, Beacon Angels Exits, Beacon Events, Boston angel investing | Tagged , , , | Leave a comment

Jaia Robotics & Imago Rehab

In another hybrid meeting held on December 14, 2022, Beacon Angels members heard the following new company funding proposals:

  • Jaia Robotics, developing “JaiaBots,” low cost, high speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters down to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab, providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation by hand-impaired stroke patients. 

We heard updates on new and follow-on funding rounds as follows:

  • Theromics‘ Series Seed extension round; and
  • NIRA’s (f/k/a Dermal Photonics) convertible note with 20% warrant coverage.

We also heard portfolio company updates.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations | Tagged , , | Leave a comment

Lightwater Biosciences & Shoreline Biome

At its monthly breakfast meeting on November 9, 2021, Beacon members met in person and remotely, where we heard new company funding proposals as follows:

  • Lightwater Biosciences (speaking in person: CEO Soo-Young Kang & Bill McCullen of Launch Capital) offering biweekly subscriptions delivering freshly made, preservative- and irritant-free, perishable, short-use cycle, single-application, skincare products; and
  • Shoreline Biome (speaking in person: Paul Denslow, CEO & CSO, Mark Driscoll) developing and selling patent-protected assays for human microbiome testing and research.

Beacon members presented their due diligence reports on the following companies:

  • Dermal Photonics, offering a patented device for home laser self-treatments superior to those of a professional dermatologist at a fraction of the cost;
  • Embrace Prevention Care, which provides Personal Prevention Care, an integrated suite of geriatric telehealth and pharmacy services designed to prevent hospitalizations and lower costs of care for older adults with heart failure and other chronic conditions; and
  • NF2 Therapeutics, developing gene replacement therapy to prevent deafness, loss of mobility and devastating brain tumors from NF2, and a targeted antibody-drug conjugate to treat meningiomas from NF2, with both therapies eligible for the FDA’s Orphan Drug Designation.

We heard updates on Beacon’s portfolio companies.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Funding Presentations | Tagged , , | Leave a comment

Embrace Prevention Care & NF2 Therapeutics

At its meeting on the morning of Tuesday, October 12, 2021, Beacon Angels members entertained new company funding proposals as follows:

  • Embrace Prevention Care (speaking in person, David Dlesk, CEO), which provides Personal Prevention Care, an integrated suite of geriatric telehealth and pharmacy services designed to prevent hospitalizations and lower costs of care for older adults with heart failure and other chronic conditions; and
  • NF2 Therapeutics (from en route to Montreal,  Michael Wootton, CEO), a biotechnology company developing gene replacement therapy to prevent deafness, loss of mobility and devastating brain tumors from NF2, and a targeted antibody-drug conjugate to treat meningiomas from NF2 and sporadic meningiomas. Both therapies are eligible for the FDA’s Orphan Drug Designation.

Members presented their due diligence report on Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productive.

CEO Ron Murphy presented in person on the extension of Theromics’ fundraising round.

We heard updates on Beacon’s new portfolio companies:

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing; and
  • Hilltop BioSciences, a veterinary biotech company offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis.
Posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations | Leave a comment

Phimentum, Reeske & Dermal Photonics

At its meeting on the morning of September 14, 2021, Beacon Angels members entertained funding proposals from:

  • Phimentum, which supplies a novel form of therapeutic braces to general dentists, enabling them to generate high profits while lowering patient costs and geographic barriers; and
  • Reeske, offering embeddable insurance technology for financial institutions to white-label life and disability insurance products to consumers, and
  • Dermal Photonics, offering a patented device for home laser self-treatments superior to those of a professional dermatologist at a fraction of the cost.

Members reviewed due diligence reports on companies consisting of:

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing;
  • Hilltop BioSciences, a veterinary biotech offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis; and
  • Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productively.

Members heard an update on the upcoming funding round of AOA Dx, as well as portfolio company updates.

Posted in Uncategorized | Leave a comment

Intraday & Soul Being

At our meeting on July 13, 2021 the members of Beacon Angels entertained new funding proposals from the following presenters:

  • Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productively; and
  • Soul Being, a healthcare services platform to help users navigate integrative medicine alternatives that improve their health while saving money for their employers and health plans.

CEO Adam Honig also delivered an update on Spiro Technologies.

Members reported on companies in due diligence consisting of: 

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing;
  • Hilltop BioSciences, a veterinary biotech company offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis; and
  • TIKI, building software for users to own the data collected on them by social media companies consisting whereby they can see their data, control when and how it is sold and used, and get paid for its sale.

We heard updates on the funding rounds of:

  • Cognoptix,RevBio, and
  • Xeno Biosciences.

Posted in Uncategorized | Tagged , , , , | Leave a comment